Publications by authors named "Peter Chin"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

38,759

Total Likes

613

Extended Reach

145,069

Social Features

22
R
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Kathleen Hawker, Paul O'Connor, Mark S Freedman, Peter A Calabresi, Jack Antel, Jack Simon, Stephen Hauser, Emmanuelle Waubant, Timothy Vollmer, Hillel Panitch

Ann Neurol· October 2009

Videos about Article: user user

2 1 19 2 4

View All Article and Social Media Activity
U
Unmet needs in the treatment and care of somatic manifestations in mucopolysaccharidosis type II: A targeted literature review.
Barbara K Burton, Daniel Fertek, Peter S Chin, Carole Ho, Roberto Giugliani

Mol Genet Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a machine learning model and direct-to-patient outreach program for targeted screening for familial hypercholesterolemia.
Kerrilynn C Hennessey, Shoshana H Bardach, Terry Sturke, Vikrant S Vaze, Roshni S Kalkur, Peter Chin

J Clin Lipidol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical resection of benign primary cardiac tumors: A 6-decade evaluation of survival and recurrence.
Annalisa Bernabei, Andrew J Toth, A Marc Gillinov, Eugene H Blackstone, Michael B Komarovsky, Peter Chin

J Thorac Cardiovasc Surg· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optilume Drug-Coated Balloon May Lower the Re-Treatment Rate Postintervention for Challenging Urethral Stricture Disease in Long-Term Follow-Up: A Prospective Cohort Study.
Zein Alhamdani, Sean Ong, Wenjie Zhong, Peter Chin

J Endourol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric-magnetic resonance imaging (mp-MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications.
Cameron James Parkin, Rajeev Jyoti, Peter Chin

BJUI Compass· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of early warning classification of risk in bladder spasm and its intervention plans guided by the rate adjustment card of continuous bladder irrigation after transurethral resection of the prostate (TURP): development and usability study.
Zheng-Zheng Ma, Dan-Dan Yang, Mei-E Niu, Xiang-Min Lu, Yan-Ting Du, Peter Chin

Transl Androl Urol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatic urethral lift for subjects in urinary retention (PULSAR): 12-Month results of a prospective controlled trial compared with real-world outcomes.
Mark Rochester, Ruth Doherty, Toby Page, Neil Barber, Rajesh Kavia, Peter Chin

BJUI Compass· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Health Education Revamped: Implementation of a Cross-Cultural Virtual Elective Through Continuous Improvement Methods.
Taseen Alam, Aarohi Mahableshwarkar, Nora Lenhard, Dua'E Zaidi, Eduardo Williams-Medina, Peter Chin

Med Sci Educ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.
Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers, Vinay M Daryani, Dolores Diaz, Peter Chin

Mov Disord· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved and optimized drug repurposing for the SARS-CoV-2 pandemic.
Sarel Cohen, Moshik Hershcovitch, Martin Taraz, Otto Kißig, Davis Issac, Peter Chin

PLoS One· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More Than 400 Uses of an Intestinal Submucosal Extracellular Matrix Patch in a Congenital Heart Program.
Li Cai Haney, Hosam F Ahmed, Alia Dani, Peter Chin, Karthik Thangappan

Ann Thorac Surg· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction.
Claus G Roehrborn, Peter T Chin, Henry H Woo

Prostate Cancer Prostatic Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction.
Claus G Roehrborn, Peter T Chin, Henry H Woo

Prostate Cancer Prostatic Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data.
Myla D Goldman, Nicholas G LaRocca, Richard A Rudick, Lynn D Hudson, Peter S Chin

Neurology· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study.
Gregg Eure, Steven Gange, Peter Walter, Ansar Khan, Charles Chabert, Peter Chin

J Endourol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostatic artery embolization: adding to the arsenal against the hapless prostate.
Peter Chin

BJU Int· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquablating urological skills.
Peter Chin

BJU Int· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
Nicholas G LaRocca, Lynn D Hudson, Richard Rudick, Dagmar Amtmann, Laura Balcer, Peter Chin

Mult Scler· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
Jerry S Wolinsky, Xavier Montalban, Stephen L Hauser, Gavin Giovannoni, Patrick Vermersch, Peter Chin

Ann Neurol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab: A New Therapeutic Paradigm for Multiple Sclerosis.
Peter Chin, Andrew C Chan

Biochemistry· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medium-term efficacy of the prostatic urethral lift.
Peter Chin, Peter Robertson

Transl Androl Urol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
Claus G Roehrborn, Jack Barkin, Steven N Gange, Neal D Shore, Jonathan L Giddens, Peter T Chin

Can J Urol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans-Peter Hartung, Peter Chin

N Engl J Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Peter Chin

N Engl J Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
Daniel Rukstalis, Prem Rashid, William K Bogache, Ronald F Tutrone, Jack Barkin, Peter T Chin

BJU Int· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis